Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Itching and treatments in atopic dermatitis (AD): results from the German AD registry TREATgermany.
Weisshaar E, Bentz P, Haufe E, Heinrich L, Apfelbacher C, Heratizadeh A, Abraham S, Harder I, Kleinheinz A, Wollenberg A, Schäkel K, Wiemers F, Ertner K, Augustin M, Wildberger J, von Kiedrowski R, Worm M, Zink A, Effendy I, Asmussen A, Pawlak M, Sticherling M, Hilgers M, Handrick C, Quist S, Schwarz B, Bell M, Staubach-Renz P, Hong-Weldemann SH, Homey B, Bruecher J, Weidinger S, Werfel T, Schmitt J; TREATgermany study group. Weisshaar E, et al. Br J Dermatol. 2023 Feb 22;188(3):430-432. doi: 10.1093/bjd/ljac070. Br J Dermatol. 2023. PMID: 36763757 No abstract available.
SARS-CoV-2 vaccination status and adverse events among patients with psoriasis-Data from the German Registries PsoBest and CoronaBest.
Valencia López MJ, Meineke A, Stephan B, Rustenbach SJ, Kis A, Thaçi D, Mrowietz U, Reich K, Staubach-Renz P, von Kiedrowski R, Bogena H, Augustin M. Valencia López MJ, et al. J Eur Acad Dermatol Venereol. 2023 Jul;37(7):e831-e833. doi: 10.1111/jdv.19039. Epub 2023 Mar 27. J Eur Acad Dermatol Venereol. 2023. PMID: 36914370 No abstract available.
Dupilumab but not cyclosporine treatment shifts the microbiome toward a healthy skin flora in patients with moderate-to-severe atopic dermatitis.
Hartmann J, Moitinho-Silva L, Sander N, Harder I, Häsler R, Rodriguez E, Haufe E, Kleinheinz A, Abraham S, Heratizadeh A, Weisshaar E, Schäkel K, Handrick C, Augustin M, Wollenberg A, Staubach-Renz P, Ertner K, Sticherling M, Schwarz B, Quist S, Wiemers F, Schenck F, Wildberger J, Tittmann L, Lieb W, Schmitt J, Werfel T, Weidinger S; TREATgermany Study Group. Hartmann J, et al. Allergy. 2023 Aug;78(8):2290-2300. doi: 10.1111/all.15742. Epub 2023 Apr 18. Allergy. 2023. PMID: 37032440
[S3-Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria - deutschsprachige Adaption der internationalen S3-Leitlinie].
Zuberbier T, Altrichter S, Bauer S, Brehler R, Brockow K, Dressler C, Fluhr J, Gaskins M, Hamelmann E, Kühne K, Merk H, Mülleneisen NK, Nast A, Olze H, Ott H, Pleimes M, Ruëff F, Staubach-Renz P, Wedi B, Maurer M. Zuberbier T, et al. J Dtsch Dermatol Ges. 2023 Feb;21(2):202-216. doi: 10.1111/ddg.14932_g. J Dtsch Dermatol Ges. 2023. PMID: 36808444 German.
Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE).
Muñoz M, Salameh P, Zajac M, Fomina D, Kovalkova E, Bobrikova E, Andrenova G, Kasperksa-Zajac A, Aulenbacher F, Herzog LS, Grekowitz EM, Buttgereit T, Giménez-Arnau AM, Planella-Fontanillas N, Pesque D, Puertolas M, Kulthanan K, Tuchinda P, Bizjak M, Košnik M, Khoshkhui M, Azad FJ, Meshkova R, Savchenko S, Makris M, Papapostolou N, Peter JG, Day C, McDougall C, Abuzakouk M, Bouillet L, Bauer A, Parisi CAS, Gregoriou S, Staubach-Renz P, Dissemond J, Kocatürk E, van Doorn MBA, Asero R, Grattan C, Thomsen SF, Du-Thanh A, Hackler Y, Weller K, Kolkhir P. Muñoz M, et al. Among authors: staubach renz p. Clin Exp Allergy. 2026 Jan 14. doi: 10.1111/cea.70215. Online ahead of print. Clin Exp Allergy. 2026. PMID: 41532284
An overview on current practices regarding the diagnosis and management of chronic urticaria in pediatrics: An EAACI Task Force report.
Arasi S, Pite H, Beken B, Alvaro-Lozano M, Brough H, Caffarelli C, Church MK, Flohr CC, Janmohamed SR, Konstantinou GN, Lau S, Maurer M, Mortz CG, Rutkowski K, Staubach-Renz P, Van der Poel LA, Zuberbier T, Weller K, Tsabouri S. Arasi S, et al. Among authors: staubach renz p. Pediatr Allergy Immunol. 2025 Aug;36(8):e70174. doi: 10.1111/pai.70174. Pediatr Allergy Immunol. 2025. PMID: 40853054
Parameters Linked With Higher Itch Severity in Chronic Spontaneous Urticaria-Chronic Urticaria Registry Results.
Stolz J, Salameh P, Asero R, Kocatürk E, Peter J, Grattan C, Herzog LS, Muñoz M, Dissemond J, Staubach-Renz P, Bauer A, Thomsen SF, Giménez-Arnau AM, Puertolas M, Bocquet A, Makris M, Gregoriou S, Khoshkhui M, Kouzegaran S, van Doorn MBA, Kasperska-Zajac A, Gąsior M, Zając M, Latysheva E, Fomina D, Kovalkova E, Andrenova G, Sedova E, Vitchuk A, Bizjak M, Košnik M, Kulthanan K, Tuchinda P, Day C, Deetlefs M, Aulenbacher F, Weller K, Kolkhir P, Metz M, Pereira MP. Stolz J, et al. Among authors: staubach renz p. J Allergy Clin Immunol Pract. 2025 Sep;13(9):2349-2360.e3. doi: 10.1016/j.jaip.2025.05.033. Epub 2025 May 28. J Allergy Clin Immunol Pract. 2025. PMID: 40447048 Free article.
German Cohort Observational Study to Investigate the Short- and Long-Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).
Homey B, Schelonke K, Schlegel CM, Bruch-Gerharz D, Weller K, Kiefer L, Stölzel U, Staubach-Renz P, Wegner J, Keller-Melchior R, Walker G, Bochno M, Bilbao P. Homey B, et al. Among authors: staubach renz p. Photodermatol Photoimmunol Photomed. 2025 Mar;41(2):e13012. doi: 10.1111/phpp.13012. Photodermatol Photoimmunol Photomed. 2025. PMID: 40082741 Free PMC article.
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Ständer S, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Metz M, Tsianakas A, Pink A, Fage S, Micali G, Weisshaar E, Sundaram H, Metelitsa A, Augustin M, Wollenberg A, Homey B, Fargnoli MC, Sofen H, Korman NJ, Skov L, Chen X, Jabbar-Lopez ZK, Piketty C, Kwatra SG; OLYMPIA 1 Investigators. Ständer S, et al. JAMA Dermatol. 2025 Feb 1;161(2):147-156. doi: 10.1001/jamadermatol.2024.4796. JAMA Dermatol. 2025. PMID: 39602139 Free PMC article. Clinical Trial.
53 results